DaVita HealthCare Partners (NYSE:DVA) CAO James K. Hilger unloaded 1,666 shares of DaVita HealthCare Partners stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $67.23, for a total transaction of $112,005.18. Following the transaction, the chief accounting officer now directly owns 13,277 shares of the company’s stock, valued at approximately $892,613. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of DaVita HealthCare Partners in a research note on Friday, May 2nd. They now have a $77.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of DaVita HealthCare Partners in a research note on Friday, May 2nd. They now have a $73.00 price target on the stock. Finally, analysts at Piper Jaffray raised their price target on shares of DaVita HealthCare Partners from $73.00 to $76.00 in a research note on Friday, May 2nd. They now have an “overweight” rating on the stock. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the stock. DaVita HealthCare Partners currently has an average rating of “Buy” and an average target price of $88.56.
DaVita HealthCare Partners (NYSE:DVA) traded down 0.30% on Friday, hitting $67.53. The stock had a trading volume of 1,261,937 shares. DaVita HealthCare Partners has a 52 week low of $52.75 and a 52 week high of $70.68. The stock has a 50-day moving average of $68.53 and a 200-day moving average of $64.57. The company has a market cap of $14.465 billion and a P/E ratio of 18.52.
DaVita HealthCare Partners (NYSE:DVA) last announced its earnings results on Thursday, May 1st. The company reported $0.85 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by $0.01. The company had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.02 billion. During the same quarter in the previous year, the company posted $1.84 earnings per share. The company’s revenue for the quarter was up 7.5% on a year-over-year basis. On average, analysts predict that DaVita HealthCare Partners will post $3.63 earnings per share for the current fiscal year.
DaVita HealthCare Partners Inc, formerly DaVita Inc, is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (NYSE:DVA).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.